EUVIMEDEUVIMED entdecken
Crossref

Tilianin obtained from Agastache mexicana inhibits monoamine oxidase and modifies depressive behavior in rats

Edgar Rodríguez-Wilson iD, Samuel Estrada-Soto iD, Moisés Rubio-Osornio, Luis Tristán-López, Gabriel Navarrete-Vázquez, Abraham Gutiérrez-Hernández, Sergio Montes

Journal of Pharmacy and Pharmacology · 2025

DOI: 10.1093/jpp/rgae117 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pharmacy and Pharmacology, 2025. Verfasst von Edgar Rodríguez-Wilson und 6 weiteren Autor:innen. Beteiligte Einrichtung: Facultad de Farmacia, Universidad Autónoma del Estado de Morelos, Avenida Universidad No. 1001, Colonia Chamilpa, Cuernavaca 62209, Morelos, México. Hauptthemen laut MEDLINE: Monoamine Oxidase Inhibitors, Plant Extracts, Monoamine Oxidase, Depression. Die Arbeit nennt 26 Literaturangaben. Gefördert von: "Consejo Nacional de Ciencia y Tecnología" Ciencia Básica, FORDECYT-PRONACES, “Consejo Nacional de Ciencia y Tecnología” Ciencia Básica.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Agastache mexicana is used in traditional medicine to treat anxiety, insomnia, pain, among others. In a previous study, the methanolic extract exerted anxiolytic and sedative effects, as observed behaviorally, associated with one of its major components, tilianin.

Objective

To assess the effect produced by the extracts and tilianin obtained from Agastache mexicana on depressive-induced behavior model and on the activity of monoamine oxidases (MAOs).

Methods

The depression experimental model consisted of the forced swimming test in rats. MAOs activity was evaluated in cortex and hippocampus from the tilianin and Agastache extracts treated rats using specific inhibitors for each isoform. The quantification of monoamines was carried out using an High Performance Liquid Chromatography method.

Results

An increase in the swimming time was observed in rodents treated with doses of 16 (226.6 ± 5.5 seconds) and 50 mg/kg (237.8 ± 5.7 seconds) of tilianin, methanolic (260.4 ± 3 seconds), and hydroalcoholic extracts (249.6 ± 2.6 seconds) at 100 mg/kg. MAOs activity was significantly decreased in brain tissue from animals treated with 16 and 50 mg/kg of tilianin, methanolic, and hydroalcoholic extracts at 100 mg/kg.

Conclusions

The tilianin effect on monoamine oxidases inhibition is confirmed, suggesting its potential use in the treatment of certain neurological disorders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Monoamine Oxidase InhibitorsPlant ExtractsMonoamine OxidaseDepressionAntidepressive AgentsAnimalsMaleRatsRats, WistarDisease Models, AnimalBehavior, AnimalSwimmingHippocampusCerebral Cortex

Stichwörter der Autor:innen

Agastache mexicanaMAObehaviordepressiontilianin

Substanzen

Monoamine Oxidase InhibitorsPlant ExtractsMonoamine OxidaseAntidepressive Agents

Autor:innen und Institutionen

  • Facultad de Farmacia, Universidad Autónoma del Estado de Morelos, Avenida Universidad No. 1001, Colonia Chamilpa, Cuernavaca 62209, Morelos, México.
  • Departamento de Neuroquímica, Instituto Nacional de Neurología y Neurocirugía "Manuel Velasco Suárez", Avenida Insurgentes Sur No. 3877, Colonia La Fama, Alcaldía Tlalpan, Ciudad de México 14269, México.
  • Laboratorio de química analítica, Unidad Académica Multidisciplinaria Reynosa-Aztlán Reynosa, Universidad Autónoma de Tamaulipas, calle 16 y lago de Chapala, Col. Aztlán, Reynosa 88740, Tamaulipas, México.

ORCID-Profile: Edgar Rodríguez-Wilson, Samuel Estrada-Soto

Förderung

  • "Consejo Nacional de Ciencia y Tecnología" Ciencia Básica
  • FORDECYT-PRONACES
  • “Consejo Nacional de Ciencia y Tecnología” Ciencia Básica

Zitieren

APA

Rodríguez-Wilson, E., Estrada-Soto, S., Rubio-Osornio, M., Tristán-López, L., Navarrete-Vázquez, G., Gutiérrez-Hernández, A., & Montes, S. (2025). Tilianin obtained from Agastache mexicana inhibits monoamine oxidase and modifies depressive behavior in rats. Journal of Pharmacy and Pharmacology. https://doi.org/10.1093/jpp/rgae117

Vancouver

Rodríguez-Wilson E, Estrada-Soto S, Rubio-Osornio M, Tristán-López L, Navarrete-Vázquez G, Gutiérrez-Hernández A, et al. Tilianin obtained from Agastache mexicana inhibits monoamine oxidase and modifies depressive behavior in rats. Journal of Pharmacy and Pharmacology. 2025. doi:10.1093/jpp/rgae117

BibTeX
@article{RodrguezWilson2025,
  author = {Rodríguez-Wilson, Edgar and Estrada-Soto, Samuel and Rubio-Osornio, Moisés and Tristán-López, Luis and Navarrete-Vázquez, Gabriel and Gutiérrez-Hernández, Abraham and Montes, Sergio},
  title = {Tilianin obtained from Agastache mexicana inhibits monoamine oxidase and modifies depressive behavior in rats},
  journal = {Journal of Pharmacy and Pharmacology},
  year = {2025},
  doi = {10.1093/jpp/rgae117}
}
Kostenlos starten →